Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ?? to all the stock mavens

I think the potential for PDSG is good, but the revenue part remains to be proven. Just based on the state of the market and the fact that it is very young makes me believe good things are ahead once the projects begin executing.

The MMP seems ready to come alive again and drive the licensing front forward. This is the original reason I invested and given all of the facts presently known, I believe this the case, and things could improve further if the remaining patents are recertified.

The next several months will be very telling regarding the future of our little company. I hope it proves to be a good one. A little more patience? What other choice do we have, having already waited 4, 6, 10 years or more?

Cheers,

DG

Share
New Message
Please login to post a reply